Smith & Nephew Orthopaedics Begins Distribution to Haiti of Trauma Implants and Instruments
20 Enero 2010 - 1:20PM
PR Newswire (US)
MEMPHIS, Tenn., Jan. 20 /PRNewswire-FirstCall/ -- Medical device
maker Smith & Nephew's (NYSE:SNN)(LSE:SN) Orthopaedics business
is making available this week more than $2 million in implants and
surgical instruments for use by orthopedic surgeons in the
treatment of survivors of last week's earthquake in Haiti. The
donation, set to arrive within days, is a wide range of orthopedic
surgical resources used to treat bone fractures. These resources
are being distributed in Haiti by Hope Force International (HFI).
Orthopedic surgeons who are trained to use these instruments and
who are travelling to Haiti to assist in the relief effort are
instructed to contact HFI (hopeforce.org) in the United States at
(615) 371-1271 or . The primary base of surgical operations and
implant distribution for HFI is King's Hospital in Port-au-Prince,
although more distribution points may be established in order to
more widely deliver the donated implants across the country. "We
have received dozens of calls from orthopedic surgeons who want to
know how to help," says Joseph M. DeVivo, president of Smith &
Nephew Orthopaedics. "We are attempting to simplify a challenging
healthcare process in the aftermath of the earthquake. Centralizing
our implants and instruments with HFI will give any US-based or
international surgeon who is trained to use them the simplest,
quickest way to apply their skills in a Haitian operating room."
"This donation reflects our commitment to serve patients on a
global basis," says DeVivo. "We have the means to help, and are
doing everything we can to connect our technology with the people
and organizations who can use it to heal those most in need." About
Smith & Nephew Smith & Nephew is a global medical
technology business, specializing in Orthopaedics, including
Reconstruction, Trauma and Clinical Therapies; Endoscopy and
Advanced Wound Management. Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading
global orthopedics companies. Smith & Nephew is dedicated to
helping improve people's lives. The Company prides itself on the
strength of its relationships with its surgeons and professional
healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The Company
operates in 32 countries around the world. Annual sales in 2008
were $3.8 billion. Forward-Looking Statements This press release
contains certain "forward-looking statements" within the meaning of
the US Private Securities Litigation Reform Act of 1995. In
particular, statements regarding planned growth in our business and
in our trading margins discussed under "Outlook" are
forward-looking statements as are discussions of our product
pipeline. These statements, as well as the phrases "aim", "plan",
"intend", "anticipate", "well-placed", "believe", "estimate",
"expect", "target", "consider" and similar expressions, are
generally intended to identify forward-looking statements. Such
forward-looking statements involve known and unknown risks,
uncertainties and other important factors (including, but not
limited to, the outcome of litigation and regulatory approvals)
that could cause the actual results, performance or achievements of
Smith & Nephew, or industry results, to differ materially from
any future results, performance or achievements expressed or
implied by such forward-looking statements. Please refer to the
documents that Smith & Nephew has filed with the U.S.
Securities and Exchange Commission under the U.S. Securities
Exchange Act of 1934, as amended, including Smith & Nephew's
most recent annual report on Form 20F, for a discussion of certain
of these factors. All forward-looking statements in this press
release are based on information available to Smith & Nephew as
of the date hereof. All written or oral forward-looking statements
attributable to Smith & Nephew or any person acting on behalf
of Smith & Nephew are expressly qualified in their entirety by
the foregoing. Smith & Nephew does not undertake any obligation
to update or revise any forward-looking statement contained herein
to reflect any change in Smith & Nephew's expectation with
regard thereto or any change in events, conditions or circumstances
on which any such statement is based. DATASOURCE: Smith &
Nephew CONTACT: Analyst-Investor Inquiries, Liz Hewitt, Smith &
Nephew, +44 (0) 20-7401-7646; or Media Inquiries, Andrew Burns,
Smith & Nephew, +1-901-399-5739, Web Site:
http://www.smith-nephew.com/
Copyright